Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6101
CALL
Genesis Energy
GEL
$1.85B
| $337K | ﹤0.01% |
15,100
-1,000
| -6% | -$23.1K |
|
6102
CALL
Pediatrix Medical
MD
$2.2B
| $337K | ﹤0.01% |
6,300
-6,900
| -52% | -$326K |
|
|
MTL
6103
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $337K | ﹤0.01% |
64,071
+25,163
| +65% | +$121K |
|
|
WLH
6104
PUT
DELISTED
WILLIAM LYON HOMES
WLH
| $337K | ﹤0.01% |
+11,600
| New | +$314K |
|
6105
CALL
Commault Systems
CVLT
$5.61B
| $336K | ﹤0.01% |
6,400
+1,000
| +19% | +$55.3K |
|
6106
CALL
Maximus
MMS
$3.11B
| $336K | ﹤0.01% |
4,700
+1,300
| +38% | +$87.5K |
|
6107
CALL
Rockwell Medical
RMTI
$28.2M
| $336K | ﹤0.01% |
525
+128
| +32% | +$90.2K |
|
|
GNMK
6108
DELISTED
GenMark Diagnostics, Inc
GNMK
| $336K | ﹤0.01% |
80,609
-7,534
| -9% | -$45.3K |
|
|
ESL
6109
PUT
DELISTED
Esterline Technologies
ESL
| $336K | ﹤0.01% |
4,500
-400
| -8% | -$32.9K |
|
6110
Braskem
BAK
$913M
| $335K | ﹤0.01% |
+12,752
| New | +$364K |
|
6111
Clearway Energy Class C
CWEN
$6.7B
| $335K | ﹤0.01% |
+17,739
| New | +$337K |
|
6112
PUT
Dolby
DLB
$5.79B
| $335K | ﹤0.01% |
5,400
+1,900
| +54% | +$115K |
|
6113
PUT
DHT Holdings
DHT
$3.02B
| $334K | ﹤0.01% |
92,900
+42,700
| +85% | +$165K |
|
6114
CALL
Ecopetrol
EC
$34.5B
| $334K | ﹤0.01% |
22,800
-5,100
| -18% | -$58.5K |
|
6115
PUT
Energy Recovery
ERII
$443M
| $334K | ﹤0.01% |
38,200
+6,300
| +20% | +$57.4K |
|
6116
PUT
Installed Building Products
IBP
$6.57B
| $334K | ﹤0.01% |
+4,400
| New | +$305K |
|
6117
Laureate Education
LAUR
$5.28B
| $334K | ﹤0.01% |
24,644
-48,018
| -66% | -$629K |
|
6118
Ligand Pharmaceuticals
LGND
$5.88B
| $334K | ﹤0.01% |
3,915
-2,148
| -35% | -$186K |
|
6119
Shenandoah Telecom
SHEN
$746M
| $334K | ﹤0.01% |
9,871
+1,380
| +16% | +$50.8K |
|
6120
PUT
Sunstone Hotel Investors
SHO
$2.06B
| $334K | ﹤0.01% |
+20,200
| New | +$334K |
|
6121
Tilly's
TLYS
$128M
| $334K | ﹤0.01% |
22,617
+6,460
| +40% | +$86.6K |
|
|
LXFT
6122
PUT
DELISTED
Luxoft Holding, Inc.
LXFT
| $334K | ﹤0.01% |
+6,000
| New | +$300K |
|
|
FM
6123
DELISTED
iShares Frontier and Select EM ETF
FM
| $334K | ﹤0.01% |
10,073
+2,395
| +31% | +$77.3K |
|
6124
PUT
Alamos Gold
AGI
$13.9B
| $333K | ﹤0.01% |
51,200
+14,400
| +39% | +$94K |
|
|
IBKC
6125
CALL
DELISTED
IBERIABANK Corp
IBKC
| $333K | ﹤0.01% |
+4,300
| New | +$331K |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.